EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

La rosuvastatina atenúa la progresión de la estenosis aórtica generada por hipertensión arterial, independientemente de sus efectos hipolipemiantes

Gustavo Giunta, Eduardo Guevara, Leandro Marziali, Leonardo Gómez Rosso, Tomás Meroño Meroño, Roberto Favaloro, Fernando Brites, Luis Cuniberti

Revista Argentina de Cardiología · 14.07.2026

DOI: 10.7775/rac.v80i1.2332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Argentina de Cardiología, online erschienen am 14.07.2026. Verfasst von Gustavo Giunta und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundThere is epidemiological evidence associating cardiovascular risk factors with aortic valve stenosis. The development of aortic valve stenosis has been recently demonstrated in a hypertensive animal model. We hypothesize that treatment with rosuvastatin modifies this transformation.ObjectiveTo evaluate the effect of rosuvastatin on the development of aortic valve stenosis.Material and MethodsHypertension was induced in 43 male NZ rabbits by a one-kidney, one-clip Goldblatt procedure. The animals were randomly assigned to 3 groups: HT (n=17) without treatment; HT+R (n=14) treated with rosuvastatin 2.5 mg/kg/day and HT+R+C (n=12) treated with rosuvastatin 2.5 mg/kg/day + cholesterol-enriched diet to keep baseline cholesterol levels. A control group (CG) underwent sham surgery (n=15). The characteristics of the aortic valve were measured by echocardiography at baseline, 3 and 6 months after inducing hypertension.ResultsAfter 6 months of follow-up, SBP and DBP presented greater increase in the group HT (49% and 40%, respectively; p

Zitieren

APA

Giunta, G., Guevara, E., Marziali, L., Rosso, L. G., Meroño, T. M., Favaloro, R., Brites, F., & Cuniberti, L. (2026). La rosuvastatina atenúa la progresión de la estenosis aórtica generada por hipertensión arterial, independientemente de sus efectos hipolipemiantes. Revista Argentina de Cardiología. https://doi.org/10.7775/rac.v80i1.2332

Vancouver

Giunta G, Guevara E, Marziali L, Rosso LG, Meroño TM, Favaloro R, et al. La rosuvastatina atenúa la progresión de la estenosis aórtica generada por hipertensión arterial, independientemente de sus efectos hipolipemiantes. Revista Argentina de Cardiología. 2026. doi:10.7775/rac.v80i1.2332

BibTeX
@article{Giunta2026,
  author = {Giunta, Gustavo and Guevara, Eduardo and Marziali, Leandro and Rosso, Leonardo Gómez and Meroño, Tomás Meroño and Favaloro, Roberto and Brites, Fernando and Cuniberti, Luis},
  title = {La rosuvastatina atenúa la progresión de la estenosis aórtica generada por hipertensión arterial, independientemente de sus efectos hipolipemiantes},
  journal = {Revista Argentina de Cardiología},
  year = {2026},
  doi = {10.7775/rac.v80i1.2332}
}
Kostenlos starten →